Effects of piracetam and iodoacetamide on erythrocyte sickling.
D000755:Anemia, Sickle Cell / Q000097:blood* / Q000188:drug therapy; D000818:Animals; D000986:Antisickling Agents; D004905:Erythrocyte Aging / Q000187:drug effects; D004913:Erythrocytes, Abnormal / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D007460:Iodoacetamide / Q000627:therapeutic use*; D007461:Iodoacetates / Q000627:therapeutic use*; D010889:Piracetam / Q000627:therapeutic use*; D011760:Pyrrolidinones / Q000627:therapeutic use*; D051381:Rats; D013789:Thalassemia / Q000097:blood* / Q000188:drug therapy
D000986:Antisickling Agents; D007461:Iodoacetates; D011760:Pyrrolidinones; D010889:Piracetam; D007460:Iodoacetamide